Published in Infect Immun on August 01, 1993
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev (1996) 2.55
The morphological transition of Helicobacter pylori cells from spiral to coccoid is preceded by a substantial modification of the cell wall. J Bacteriol (1999) 1.69
Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol (2014) 1.40
A lytic transglycosylase of Neisseria gonorrhoeae is involved in peptidoglycan-derived cytotoxin production. Infect Immun (2002) 1.31
Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin. Infect Immun (2001) 1.25
Mutations affecting peptidoglycan acetylation in Neisseria gonorrhoeae and Neisseria meningitidis. Infect Immun (2005) 1.11
Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc Natl Acad Sci U S A (1994) 1.09
Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev (2016) 1.07
Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide. Infect Immun (2000) 1.05
Induction of proinflammatory cytokines from human respiratory epithelial cells after stimulation by nontypeable Haemophilus influenzae. Infect Immun (2000) 1.05
Keratinocyte proinflammatory responses to adherent and nonadherent group A streptococci. Infect Immun (1997) 1.03
Mutations in ampG or ampD affect peptidoglycan fragment release from Neisseria gonorrhoeae. J Bacteriol (2008) 0.93
The lytic transglycosylases of Neisseria gonorrhoeae. Microb Drug Resist (2012) 0.93
Pertussis pathogenesis--what we know and what we don't know. J Infect Dis (2014) 0.92
The immune profile associated with acute allergic asthma accelerates clearance of influenza virus. Immunol Cell Biol (2014) 0.88
Peptidoglycan fragment release from Neisseria meningitidis. Infect Immun (2013) 0.81
Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro. Infect Immun (1994) 0.79
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol (1984) 5.51
Interleukin-1 and its biologically related cytokines. Adv Immunol (1989) 4.57
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature (1990) 4.46
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol (1990) 3.89
Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci U S A (1985) 3.39
Selective cytokine production by epithelial cells following exposure to Escherichia coli. Infect Immun (1993) 2.83
Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science (1990) 2.59
Pertussis. Medicine (Baltimore) (1975) 2.41
Induction of human interleukin-1 by toxic-shock-syndrome toxin-1. J Infect Dis (1985) 2.37
Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA. Proc Natl Acad Sci U S A (1988) 2.26
cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci U S A (1991) 2.16
Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells. J Immunol (1986) 2.14
Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis (1992) 2.09
The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J Biol Chem (1988) 1.95
Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells. Infect Immun (1982) 1.94
Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1. J Immunol (1985) 1.86
Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor. Cell Immunol (1980) 1.76
Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells. Eur J Immunol (1989) 1.72
Monoclonal antibodies to murine IL-1 alpha. Production, characterization, and inhibition of membrane-associated IL-1 activity. J Immunol (1988) 1.63
Biological activities and chemical composition of purified tracheal cytotoxin of Bordetella pertussis. Infect Immun (1989) 1.60
The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. J Infect Dis (1978) 1.59
Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci U S A (1990) 1.57
Pathogenesis of infection with Bordetella pertussis in hamster tracheal organ culture. J Infect Dis (1977) 1.57
The interleukin 1 receptor. Dynamics of interleukin 1 binding and internalization in T cells and fibroblasts. J Immunol (1987) 1.49
Selective isolation and culture of a proliferating epithelial cell population from the hamster trachea. In Vitro (1980) 1.47
Muramyl peptides: immunomodulators, sleep factors, and vitamins. Med Res Rev (1984) 1.40
Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide. J Infect Dis (1980) 1.35
IL-1 and its receptor are translocated to the nucleus. J Immunol (1990) 1.32
Binding, internalization, and intracellular localization of interleukin-1 beta in human diploid fibroblasts. J Biol Chem (1988) 1.27
Primary structure of the peptidoglycan-derived tracheal cytotoxin of Bordetella pertussis. Biochemistry (1989) 1.27
Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol (1991) 1.26
Induction of interleukin 1 by synthetic and naturally occurring muramyl peptides. Fed Proc (1986) 1.07
Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides. Fed Proc (1986) 1.06
Purification and characterization of human recombinant precursor interleukin 1 beta. J Biol Chem (1989) 1.00
Effects of Bordetella pertussis infection on human respiratory epithelium in vivo and in vitro. Infect Immun (1991) 0.98
Receptor-mediated endocytosis and nuclear transport of human interleukin 1 alpha. Biochem J (1989) 0.96
Muramyl peptides as possible endogenous immunopharmacological mediators. Microbiol Immunol (1983) 0.91
Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptides. Cell Immunol (1987) 0.88
Somnogenic activity of immune response modifiers. Trends Pharmacol Sci (1990) 0.87
Binding of immunogenic peptides to Ia histocompatibility molecules. Nature (1985) 8.39
Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med (1972) 8.25
Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med (1971) 8.22
Antigen-presenting function of the macrophage. Annu Rev Immunol (1984) 7.83
Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A (1993) 6.33
Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin. J Exp Med (1971) 5.43
Critical role of determinant presentation in the induction of specific responses in immunocompetent lymphocytes. J Exp Med (1973) 5.30
Ligand-induced movement of lymphocyte membrane macromolecules. I. Analysis by immunofluorescence and ultrastructural radioautography. J Exp Med (1972) 5.01
Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A (1982) 4.85
The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages. Adv Immunol (1981) 4.72
Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J Immunol (1989) 4.70
The regulatory role of macrophages in antigenic stimulation. Adv Immunol (1972) 4.69
Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature (1990) 4.59
Classification of Histoplasma capsulatum isolates by restriction fragment polymorphisms. J Bacteriol (1986) 4.55
The basis for the immunoregulatory role of macrophages and other accessory cells. Science (1987) 4.51
Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction. Adv Immunol (1976) 4.18
Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect Immun (1991) 4.18
Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J Immunol (1981) 3.94
Prostaglandins modulate macrophage Ia expression. Nature (1982) 3.83
Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv Immunol (1967) 3.83
Activated macrophages induce vascular proliferation. Nature (1977) 3.74
Antigen presentation: comments on its regulation and mechanism. J Immunol (1984) 3.68
Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol (1982) 3.61
A T cell-independent mechanism of macrophage activation by interferon-gamma. J Immunol (1987) 3.55
Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol (1994) 3.50
Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev (1991) 3.49
Regulation of macrophage populations. I. Preferential induction of Ia-rich peritoneal exudates by immunologic stimuli. J Immunol (1980) 3.46
Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J Immunol (1984) 3.41
Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci U S A (1985) 3.39
Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun (1993) 3.38
Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J Med Vet Mycol (1988) 3.24
Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci U S A (1991) 3.09
Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature (1987) 3.08
A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med (1978) 3.02
Macrophage-T cell interactions involving Listeria monocytogenes--role of the H-2 gene complex. J Immunol (1979) 2.93
Persistence of immunogenicity of antigen after uptake by macrophages. J Exp Med (1968) 2.93
Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci U S A (1997) 2.89
Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol (1993) 2.73
The costimulatory function of antigen-presenting cells. Immunol Today (1990) 2.71
The binding of clathrin triskelions to membranes from coated vesicles. Cell (1981) 2.70
The immune response of mice to antigen in macrophages. Immunology (1968) 2.67
An ultrastructural study of lymphocytes with surface-bound immunoglobulin. J Exp Med (1972) 2.65
When to use fluconazole. Lancet (1995) 2.63
Two distinct mechanisms for redistribution of lymphocyte surface macromolecules. I. Relationship to cytoplasmic myosin. J Cell Biol (1978) 2.54
The modulation of lymphocyte functions by molecules secreted by macrophages. I. Description and partial biochemical analysis. J Exp Med (1975) 2.54
Intracellular parasitism by Histoplasma capsulatum: fungal virulence and calcium dependence. Science (2000) 2.54
Diversity among clinical isolates of Histoplasma capsulatum detected by polymerase chain reaction with arbitrary primers. J Bacteriol (1992) 2.54
Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J Immunol (1990) 2.54
Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism. J Immunol (1986) 2.51
Ligand-induced movement of lymphocyte membrane macromolecules. II. Mapping of surface moieties. J Exp Med (1972) 2.49
Antigen binding and capping by lymphocytes of genetic nonresponder mice. J Exp Med (1972) 2.46
The regulation of lymphocyte functions by the macrophage. Immunol Rev (1978) 2.43
Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas. Proc Natl Acad Sci U S A (1984) 2.40
Demonstration of a soluble mediator that induces exudates rich in Ia-positive macrophages. J Exp Med (1980) 2.38
Association rules and data mining in hospital infection control and public health surveillance. J Am Med Inform Assoc (1998) 2.38
Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA. Proc Natl Acad Sci U S A (1988) 2.26
Antigenic competition at the level of peptide-Ia binding. Proc Natl Acad Sci U S A (1986) 2.23
T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc Natl Acad Sci U S A (1988) 2.21
Redistribution of myosin accompanying capping of surface Ig. J Exp Med (1977) 2.18
Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J Immunol (1981) 2.18
Secretory function of mononuclear phagocytes: a review. Am J Pathol (1976) 2.12
An inhibitor of cell proliferation released by cultures of macrophages. Proc Natl Acad Sci U S A (1974) 2.11
Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J Immunol (1991) 2.08
The immunogenicity of antigen bound to the plasma membrane of macrophages. J Exp Med (1970) 2.08
Ligand-induced movement of lymphocyte membrane macromolecules. 3. Relationship between the formation and fate of anti-Ig-surface Ig complexes and cell metabolism. J Exp Med (1973) 2.08
A defect in the antigen-presenting function of macrophages from neonatal mice. Nature (1979) 2.07
Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice. Proc Natl Acad Sci U S A (1992) 2.06
A role of macrophages in the stimulation of immune responses by adjuvants. J Immunol (1969) 2.06
Two biological activities regulating cell proliferation found in cultures of peritoneal exudate cells. Nature (1975) 2.04
Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature (1994) 2.02
Induction of cytocidal macrophages after in vitro interactions between Listeria-immune T cells and macrophages--role of H-2. J Immunol (1979) 2.00
Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimens. J Clin Microbiol (1998) 1.97
Immunity to Listeria infection. Curr Opin Immunol (2000) 1.97
The specific binding of Listeria monocytogenes-immune T lymphocytes to macrophages. I. Quantitation and role of H-2 gene products. J Exp Med (1979) 1.97
Cutting edge: paradigm revisited: antibody provides resistance to Listeria infection. J Immunol (1999) 1.96
Persistence of antigen on the surface of macrophages. Nature (1969) 1.95
Distribution of actin in spreading macrophages: a comparative study on living and fixed cells. J Cell Biol (1983) 1.95
Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells. Infect Immun (1982) 1.94
Properties and some uses of anti-macrophage antibodies. Nature (1968) 1.94
Listeria monocytogenes induces apoptosis of infected hepatocytes. J Immunol (1996) 1.94
Receptor-mediated inactivation of early B lymphocytes. Nature (1975) 1.90
Experimental allergic glomerulonephritis induced in the rabbit with heterologous renal antigens. J Exp Med (1967) 1.90
Redistribution and fate of Ig complexes on surface of B lymphocytes: functional implications and mechanisms. Transplant Rev (1973) 1.88
IA antigens and antigen-presenting function of thymic macrophages. J Immunol (1980) 1.87
The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol (1996) 1.87
Intracellular antibody neutralizes Listeria growth. Immunity (2001) 1.86
Antigen processing and intracellular Ia. Possible roles of endocytosis and protein synthesis in Ia function. J Immunol (1989) 1.84
Histoplasma variation and adaptive strategies for parasitism: new perspectives on histoplasmosis. Clin Microbiol Rev (1991) 1.83
Anti-Ig-triggered movements of lymphocytes-specificity and lack of evidence for directional migration. J Immunol (1975) 1.82
Histoplasma capsulatum modulates the acidification of phagolysosomes. J Exp Med (1993) 1.82
Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity (1997) 1.82
Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell (1991) 1.81
Effects of bacterial products on lymphocytes and macrophages: their possible role in natural resistance to listeria infetion in mice. J Immunol (1974) 1.79
Isolation and characterization of spontaneous avirulent variants of Histoplasma capsulatum. Infect Immun (1987) 1.78
Location of the initial cleavage sites in mouse pre-rRNA. Mol Cell Biol (1983) 1.77
Synthesis and release of thymidine by macrophages. J Immunol (1977) 1.77
Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity (2000) 1.77
Experimental allergic glomerulonephritis induced in the rabbit with homologous renal antigens. J Exp Med (1967) 1.76
Inhibition of surface capping of macromolecules by local anaesthetics and tranquillisers. Nature (1974) 1.75